C. diff is a bacteria that causes severe intestinal illness; it is difficult to study and treat. Approximately 1 in 6 patients infected with C. diff will be reinfected within two months.
The study, published in Nature, analyzed stool samples from 54 pediatric patients infected with C. diff. Researchers found these patients had high levels of Enterococcus and established a positive correlation between enterococcal and C. diff burdens.
“When we talk about bacterial infections, we often just think of the pathogen itself, but the ‘bystanders’ in the gut can have a huge impact on the course of infection,” senior author Joseph Zackular, PhD, investigator and assistant professor of pathology and laboratory medicine at Children’s Hospital of Philadelphia, told Science Daily. “This study reveals that the coincidence of two pathogenic organisms — Enterococcus and C. difficile — is more than a coincidence; they truly take advantage of each other. Understanding this relationship, as well as other factors that contribute to clinical outcomes of C. difficile infection, is essential for combating this urgent public health challenge.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
